Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

Mosunetuzumab with Polatuzumab Vedotin: Subgroup Analyses in Patients (pts) with Primary Refractory or Early Relapsed Large B-cell Lymphoma (LBCL).

Sarit Assouline,Lihua Elizabeth Budde,Julio C. Chavez,Catherine S. Diefenbach,Kathleen Anne Dorritie,Nilanjan Ghosh,Adam J. Olszewski,Izidore S. Lossos,Amitkumar Mehta,Dipenkumar Modi,Seema Naik,Stephen Douglas Smith,Sneha Makadia,Song Pham, Hao Wu,Connie Lee Batlevi,Iris To,Michael C. Wei,Manali Kamdar

Clinical Lymphoma Myeloma and Leukemia（2024）

Cited 0|Views3

Key words

ABCL,antibody,bispecific,large B-cell lymphoma,relapsed/refractory

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined